scispace - formally typeset
J

Joseph L. Izzo

Researcher at University at Buffalo

Publications -  232
Citations -  53804

Joseph L. Izzo is an academic researcher from University at Buffalo. The author has contributed to research in topics: Blood pressure & Systolic hypertension. The author has an hindex of 46, co-authored 229 publications receiving 51755 citations. Previous affiliations of Joseph L. Izzo include Erie County Medical Center & LSU Health Sciences Center New Orleans.

Papers
More filters
Journal ArticleDOI

Plasma dihydroxyphenylglycol (DHPG) in the in vivo assessment of human neuronal norepinephrine metabolism.

TL;DR: The coupling of measurements of plasma NE with its deaminated metabolites and DHPG may improve understanding of human NE metabolism and neuronal NE reuptake.
Journal ArticleDOI

Brief report: Internal medicine residents', attendings', and nurses' perceptions of the night float system.

TL;DR: More residents than both attendings and nurses had positive opinions regarding the night float system, particularly in relation to patient care, while nurses had negative perceptions of resident performance in the setting of the nightFloat system.
Journal ArticleDOI

REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention

TL;DR: This scientific statement summarizes the published data relating to the treatment of hypertension in the context of CAD prevention and management and attempts to develop recommendations that will be appropriate for both BP reduction and the management of CAD in its various manifestations.
Journal ArticleDOI

Sympathoadrenal activity, catecholamines, and the pathogenesis of vasculopathic hypertensive target-organ damage.

TL;DR: This review examines the evidence that damage to the kidneys, eyes, and brain can be grouped under the basic heading of hypertensive vasculopathy and hypothesis is put forward that norepinephrine is a major contributor and an overlooked cardiovascular risk factor.